Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Alpine Immune brings in $48mm through Series A round

Executive Summary

Immunotherapies start-up Alpine Immune Sciences (AIS) raised $48mm in its Series A round led by OrbiMed Advisors. Frazier Healthcare Partners and Alpine BioVentures also participated. (Alpine BioVentures provided $1.25mm in seed funding to the company when it launched last year.)
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register